The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $118.44

Today's change-2.30 -1.90%
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $118.44

Today's change-2.30 -1.90%
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc crosses below 50-day moving average

USANA Health Sciences Inc closed sharply lower Friday, dropping (U.S.)$2.30 or 1.90% to (U.S.)$118.44 and crossing below its 50-day moving average. Over the last five days, shares have lost 3.38% and are down 7.29% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $120.26
  • Previous close(U.S.) $120.74
  • High(U.S.) $122.18
  • Low(U.S.) $116.53
  • Bid / Ask-- / --
  • YTD % change-7.29%
  • Volume136,236
  • Average volume (10-day)93,112
  • Average volume (1-month)109,445
  • Average volume (3-month)134,451
  • 52-week range(U.S.) $92.00 to (U.S.) $176.88
  • Beta1.19
  • Trailing P/E16.49×
  • P/E 1 year forward14.74×
  • Forward PEG1.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.18
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.31%

Based on its net profit margin of 10.31%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 02, 201601/02/2016Oct 03, 201510/03/2015Jul 04, 201507/04/2015Apr 04, 201504/04/2015
Revenue233233233219
Total other revenue--------
Total revenue233233233219
Gross profit192192193181
Total cost of revenue40414038
Total operating expense197195194190
Selling / general / administrative157154154151
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income35383930
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax36383930
Income after tax24262520
Income tax, total12131310
Net income24262520
Total adjustments to net income--------
Net income before extra. items24262520
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24262520
Inc. avail. to common incl. extra. items24262520
Diluted net income24262520
Dilution adjustment----0--
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share1.831.921.921.50
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.831.921.921.50